Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


10.06.2019

1 Am J Respir Cell Mol Biol
1 Am J Respir Crit Care Med
1 Ann Oncol
1 Ann Thorac Surg
2 BMJ
1 Clin Cancer Res
7 Clin Lung Cancer
3 Eur J Cardiothorac Surg
1 Eur Respir J
2 Int J Cancer
1 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
2 J Clin Oncol
1 J Thorac Cardiovasc Surg
3 J Thorac Oncol
1 N Engl J Med
2 Oncol Rep
1 Oncologist
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Cell Mol Biol

  1. REYFMAN PA, Gottardi CJ
    IPF and Lung Cancer: Finding Similarities within Differences.
    Am J Respir Cell Mol Biol. 2019 Jun 5. doi: 10.1165/rcmb.2019-0172.
    PubMed     Text format    


    Am J Respir Crit Care Med

  2. GARMENDIA I, Pajares MJ, Hermida-Prado F, Ajona D, et al
    YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.
    Am J Respir Crit Care Med. 2019 Jun 5. doi: 10.1164/rccm.201807-1292.
    PubMed     Text format     Abstract available


    Ann Oncol

  3. PASTORINO U, Silva M, Sestini S, Sabia F, et al
    Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
    Ann Oncol. 2019 Jun 5. pii: 5511622. doi: 10.1093.
    PubMed     Text format    


    Ann Thorac Surg

  4. GAO HJ, Jiang ZH, Gong L, Ma K, et al
    Video-assisted Versus Thoracotomy Sleeve Lobectomy for Lung Cancer: a Propensity Matched Analysis.
    Ann Thorac Surg. 2019 Jun 1. pii: S0003-4975(19)30715.
    PubMed     Text format     Abstract available


    BMJ

  5. MAHASE E
    Lung cancer: audit shows improvement in surgery survival.
    BMJ. 2019;365:l4024.
    PubMed     Text format    

  6. NEAL RD, Sun F, Emery JD, Callister ME, et al
    Lung cancer.
    BMJ. 2019;365:l1725.
    PubMed     Text format    


    Clin Cancer Res

  7. CHALISHAZAR MD, Wait SJ, Huang F, Ireland AS, et al
    MYC-driven small cell lung cancer is metabolically distinct and vulnerable to arginine depletion.
    Clin Cancer Res. 2019 Jun 4. pii: 1078-0432.CCR-18-4140.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  8. PINSOLLE J, Mondet J, Duruisseaux M, d'Alnoncourt S, et al
    A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30105.
    PubMed     Text format    

  9. KIM R, Keam B, Hahn S, Ock CY, et al
    First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30113.
    PubMed     Text format     Abstract available

  10. IKARI T, Sakakibara-Konishi J, Yamamoto G, Kitai H, et al
    Response to First-Line Osimertinib Treatment in Non-Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30106.
    PubMed     Text format    

  11. MENDOZA DP, Stowell J, Muzikansky A, Shepard JO, et al
    Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30110.
    PubMed     Text format     Abstract available

  12. RADES D, Motisi L, Veninga T, Conde-Moreno A, et al
    Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Apr 26. pii: S1525-7304(19)30085.
    PubMed     Text format     Abstract available

  13. SCHILD SE, Zhao L, Wampfler JA, Daniels TB, et al
    Small-cell Lung Cancer in Very Elderly (>/= 80 Years) Patients.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30111.
    PubMed     Text format     Abstract available

  14. MEZQUITA L, Benito A, Ruano-Ravina A, Zamora J, et al
    Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2019 May 3. pii: S1525-7304(19)30100.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  15. YUN JK, Lee GD, Choi S, Kim HR, et al
    Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Jun 5. pii: 5511574. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. STILES BM, Mao J, Harrison S, Lee B, et al
    Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Eur J Cardiothorac Surg. 2019 Jun 5. pii: 5511701. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. MARIJIC P, Walter J, Schneider C, Schwarzkopf L, et al
    Cost and survival of video-assisted thoracoscopic lobectomy versus open lobectomy in lung cancer patients: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2019 Jun 3. pii: 5510143. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur Respir J

  18. SEIJO LM, Soriano JB, Peces-Barba G
    New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD.
    Eur Respir J. 2019;53.
    PubMed     Text format    


    Int J Cancer

  19. LIU YN, Tsai MF, Wu SG, Chang TH, et al
    Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer.
    Int J Cancer. 2019 Jun 4. doi: 10.1002/ijc.32487.
    PubMed     Text format     Abstract available

  20. BECKER N, Motsch E, Trotter A, Heussel CP, et al
    Lung cancer mortality reduction by LDCT screening - results from the randomised German LUSI trial.
    Int J Cancer. 2019 Jun 4. doi: 10.1002/ijc.32486.
    PubMed     Text format     Abstract available


    Int J Oncol

  21. LIU Y, Xie S, Zeng J, Song X, et al
    Adenylyl cyclaseassociated protein 1targeted nanoparticles as a novel strategy for the treatment of metastatic nonsmall cell lung cancer.
    Int J Oncol. 2019 Jun 6. doi: 10.3892/ijo.2019.4822.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  22. BADIYAN SN, Robinson CG, Bradley JD
    Radiation Toxicity in Lung Cancer Patients: The Heart of the Problem?
    Int J Radiat Oncol Biol Phys. 2019;104:590-592.
    PubMed     Text format    


    J Cancer Res Clin Oncol

  23. PARK CK, Kim JE, Kim MS, Kho BG, et al
    Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2019 Jun 1. pii: 10.1007/s00432-019-02944.
    PubMed     Text format     Abstract available


    J Clin Oncol

  24. GARON EB, Hellmann MD, Rizvi NA, Carcereny E, et al
    Five-Year Overall Survival for Patients With Advanced NonSmall-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study.
    J Clin Oncol. 2019 Jun 2:JCO1900934. doi: 10.1200/JCO.19.00934.
    PubMed     Text format     Abstract available

  25. RANGACHARI D, Costa DB
    From Hope to Reality: Durable Overall Survival With Immune Checkpoint Inhibitors for Advanced Lung Cancer.
    J Clin Oncol. 2019 Jun 2:JCO1901207. doi: 10.1200/JCO.19.01207.
    PubMed     Text format    


    J Thorac Cardiovasc Surg

  26. ALTORKI N, Lee B
    Commentary: Lobectomy or sublobar resection for early lung cancer: One small step for surgeons, one giant step for patients.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30903.
    PubMed     Text format    


    J Thorac Oncol

  27. RUTKOWSKI J, Saad ED, Burzykowski T, Buyse M, et al
    Chronological Trends in Progression-free, Overall and Post-progression Survival in First-line Therapy for Advanced Non-small-cell Lung Cancer.
    J Thorac Oncol. 2019 Jun 1. pii: S1556-0864(19)30415.
    PubMed     Text format     Abstract available

  28. LANGER CJ, Redman MW, Wade JL 3rd, Aggarwal C, et al
    Brief Report: SWOG S1400B (NCT02785913), A Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).
    J Thorac Oncol. 2019 May 31. pii: S1556-0864(19)30414.
    PubMed     Text format     Abstract available

  29. SHEPSHELOVICH D, Xu W, Lu L, Fares A, et al
    Body mass index (BMI), BMI change, and overall survival in small cell and non-small cell lung cancer patients: a pooled analysis of the International Lung Cancer Consortium.
    J Thorac Oncol. 2019 Jun 1. pii: S1556-0864(19)30416.
    PubMed     Text format     Abstract available


    N Engl J Med

  30. YU D, Blair JEA
    A STEMI Mimic.
    N Engl J Med. 2019;380:e41.
    PubMed     Text format    


    Oncol Rep

  31. LIU Q, Huo Y, Zheng H, Zhao J, et al
    Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of nonsmall cell lung cancer cells via the HMGB1/RAGE axis and the NFkappaB/STAT3 pathway.
    Oncol Rep. 2019 May 30. doi: 10.3892/or.2019.7176.
    PubMed     Text format     Abstract available

  32. OKITA R, Maeda A, Shimizu K, Nojima Y, et al
    Effect of platinumbased chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death1 ligand 1 and HLA class I in nonsmall cell lung cancer.
    Oncol Rep. 2019 Jun 3. doi: 10.3892/or.2019.7185.
    PubMed     Text format     Abstract available


    Oncologist

  33. FINTELMANN FJ, Troschel FM, Kuklinski MW, McDermott S, et al
    Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung Cancer.
    Oncologist. 2019 May 31. pii: theoncologist.2019-0158.
    PubMed     Text format     Abstract available


    PLoS One

  34. LIU J, Liu S, Deng X, Rao J, et al
    MicroRNA-582-5p suppresses non-small cell lung cancer cells growth and invasion via downregulating NOTCH1.
    PLoS One. 2019;14:e0217652.
    PubMed     Text format     Abstract available

  35. NAKAMURA H, Fujii K, Gupta V, Hata H, et al
    Identification of key modules and hub genes for small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma by weighted gene co-expression network analysis of clinical tissue-proteomes.
    PLoS One. 2019;14:e0217105.
    PubMed     Text format     Abstract available

  36. RICE SJ, Liu X, Wang HG, Belani CP, et al
    EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer.
    PLoS One. 2019;14:e0217657.
    PubMed     Text format     Abstract available

  37. BYCHKOV M, Shenkarev Z, Shulepko M, Shlepova O, et al
    Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of alpha7 nicotinic acetylcholine receptors.
    PLoS One. 2019;14:e0217339.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: